Grufity logoGrufity logo

OMCL

52.05USD+1.00(+1.96%)Market Closed

Omnicell Inc

Market Summary

USD52.05+1.00Market Closed
1.96%

OMCL Alerts

OMCL Stock Price

RSI Chart

Valuation

Market Cap

3.5B

Price/Earnings

56.99

Price/Sales

2.75

Price/Cashflow

44.8

MarketCap/EBT

75.26

Price/Sales

Profitability

Operating Margin

82.47%

EBT Margin

3.65%

Return on Equity

5.54%

Return on Assets

2.84%

Fundamentals

Revenue

Revenue (TTM)

1.3B

Revenue Y/Y

17.43%

Revenue Q/Q

5.03%

Earnings

Earnings (TTM)

48.0M

Earnings Y/Y

-42.78%

Earnings Q/Q

84.96%

Price Action

52 Week Range

46.19185.28
(Low)(High)

Last 7 days

-1.1%

Last 30 days

-32.9%

Last 90 days

-51.9%

Trailing 12 Months

-71.0%

Financial Health

Current Ratio

2.11

Investor Care

Shares Dilution (1Y)

1.61%

Diluted EPS (TTM)

1.01

Peers (Alternatives to Omnicell)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
183.3B
31.3B
5.22% -15.14%
27.1
5.87
11.35% 14.95%
115.4B
31.1B
-7.32% -29.47%
22.17
3.71
-1.67% 34.08%
27.9B
5.8B
0.98% 20.75%
47.36
4.81
5.93% -26.79%
26.5B
2.0B
12.37% -36.20%
67.34
13.25
20.29% -7.22%
MID-CAP
9.0B
3.5B
11.88% 31.28%
-117.28
2.58
7.15% -34.72%
5.1B
348.4M
25.77% -5.77%
-116.67
17.03
73.31% -6.97%
4.8B
2.3B
3.22% -73.96%
-0.48
2.14
24.79% -1114.68%
3.5B
1.3B
-32.88% -71.05%
56.99
2.75
22.34% -40.14%
2.8B
234.2M
0.32% 74.54%
-326.57
11.85
18.02% 12.02%
SMALL-CAP
1.5B
163.2M
-21.49% -53.63%
-10.23
9.27
35.13% -252.35%
1.5B
245.2M
-7.39% -60.45%
-8.12
5.99
36.52% -260.24%
278.8M
63.1M
24.27% -71.29%
-39.93
4.35
9.93% -1043.45%
94.0M
302.5M
7.71% -69.67%
-0.81
0.3
-0.73% -57.66%
48.1M
29.3M
-4.76% -76.92%
-3.71
1.49
-19.35% -69.01%
6.0M
6.8M
-15.06% -87.91%
-0.27
0.74
-21.00% -36.01%

Financials for Omnicell

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue4.1%1,3091,2581,1991,1321,070
Gross Profit2.0%617604582555529
Operating Expenses4.3%569546507465431
  S&GA Expenses3.9%470453423389362
  R&D Expenses6.1%9993857669
Earnings Before Taxes-13.1%4046586673
Net Income-20.7%4861727880
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets2.3%2,1802,1312,1232,1422,051
  Current Assets7.8%849788776781889
    Cash Equivalents8.8%266245265349482
  Inventory-2.2%147150137120104
  Net PPE8.0%8882777165
  Goodwill-0.4%731734740739616
Liabilities0.5%1,0441,0391,048996940
  Current Liabilities0.8%377374951876339
Shareholder's Equity3.9%1,1351,0931,0751,1471,111
  Retained Earnings4.2%419402393369355
  Additional Paid-In Capital3.3%1,0319989831,0251,003
Accumulated Depreciation-5.5%123130126122116
Shares Outstanding0.8%4544444444
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations-28.3%5577158232249
  Share Based Compensation5.9%6562585350
Cashflow From Investing43.2%-233.80-411.57-418.10-412.50-456.80
Cashflow From Financing-107.0%-17.85-8.62-0.354761
  Buy Backs0%52525200
* denotes actual numbers (not divided by Millions)

Risks

What is the probability of a big loss on OMCL?

78.5%


Probability that Omnicell stock will be more than 20% underwater in next one year

35%


Probability that Omnicell stock will be more than 30% underwater in next one year.

11.9%


Probability that Omnicell stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does OMCL drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Omnicell was unfortunately bought at previous high price.

Returns

Cumulative Returns on OMCL

13.1%


10-Year Cumulative Returns

8.3%


7-Year Cumulative Returns

0.8%


5-Year Cumulative Returns

-13.7%


3-Year Cumulative Returns

What are the long-term rolling returns for OMCL?

FIve years rolling returns for Omnicell.

Which funds bought or sold OMCL recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-22
Capital Impact Advisors, LLC
REDUCED
-0.82
-630,000
779,000
0.78%
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
2,343,000
2,343,000
0.03%
2022-11-21
FourThought Financial, LLC
ADDED
1.04
-37,000
127,000
0.02%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
REDUCED
-2.56
-1,735,000
5,079,000
0.01%
2022-11-21
17 CAPITAL PARTNERS, LLC
UNCHANGED
-
-75,000
243,000
0.33%
2022-11-17
CENTRAL TRUST Co
UNCHANGED
-
-3,000
11,000
-%
2022-11-17
M&T Bank Corp
ADDED
15.43
-119,000
907,000
-%
2022-11-16
Retirement Systems of Alabama
NEW
-
5,046,000
5,046,000
0.02%
2022-11-16
GLENMEDE TRUST CO NA
ADDED
27.44
-33,000
1,273,000
0.01%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
ADDED
28.54
-6,000
354,000
-%

1–10 of 42

Latest Funds Activity

Are funds buying OMCL calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own OMCL

Omnicell News

Marketscreener.com

Omnicell to Present at the Piper Sandler 34th Annual Healthcare Conference.4 days ago

OMCL Fair Value

Recent SEC filings of Omnicell

View All Filings
Date Filed Form Type Document
Nov 17, 2022
4
Insider Trading
Nov 04, 2022
10-Q
Quarterly Report
Nov 02, 2022
8-K
Current Report
Oct 21, 2022
8-K
Current Report
Sep 20, 2022
8-K
Current Report
Sep 20, 2022
8-K
Current Report
Sep 19, 2022
4
Insider Trading
Sep 19, 2022
4
Insider Trading
Aug 30, 2022
4
Insider Trading
Aug 24, 2022
4
Insider Trading

Latest Insider Trading transactions for OMCL

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-15
SPEARS JOSEPH BRIAN
SOLD FOR TAXES
-2,792.5
55.85
-50
CHIEF ACCOUNTING OFFICER & SVP
2022-09-15
SPEARS JOSEPH BRIAN
SOLD (Taxes)
-13,214.9
95.76
-138
CHIEF ACCOUNTING OFFICER & SVP
2022-09-15
Manley Corey J
SOLD (Taxes)
-6,798.96
95.76
-71
SR. VP & CHIEF LEGAL OFFICER
2022-08-26
Kuipers Peter J.
SOLD
-1,678,520
108.292
-15,500
EXECUTIVE V P& CFO
2022-08-26
Kuipers Peter J.
ACQUIRED
1,083,080
69.876
15,500
EXECUTIVE V P& CFO
2022-08-22
Kuipers Peter J.
SOLD
-1,165,230
105.93
-11,000
EXECUTIVE V P& CFO
2022-08-22
Kuipers Peter J.
ACQUIRED
486,750
44.25
11,000
EXECUTIVE V P& CFO
2022-08-16
LIPPS RANDALL A
SOLD
-1,443,480
111.037
-13,000
CHAIRMAN, PRESIDENT AND CEO
2022-08-15
SPEARS JOSEPH BRIAN
SOLD (Taxes)
-22,558.2
112.23
-201
CHIEF ACCOUNTING OFFICER & SVP
2022-08-12
LIPPS RANDALL A
GIFTED
-
-
-12,000
CHAIRMAN, PRESIDENT AND CEO

1–10 of 50

Randall A. Lipps
3800
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.

OMCL Income Statement

2022-09-30
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues$ 348,059$ 296,402$ 998,273$ 820,984
Cost of revenues188,964149,623531,039415,624
Gross profit159,095146,779467,234405,360
Operating expenses:    
Research and development25,17119,47776,55653,770
Selling, general, and administrative115,45997,910354,644273,672
Total operating expenses140,630117,387431,200327,442
Income from operations18,46529,39236,03477,918
Interest and other income (expense), net(1,148)(6,065)(2,973)(18,715)
Income before provision for income taxes17,31723,32733,06159,203
Provision for (benefit from) income taxes543(5,990)(995)(4,665)
Net income$ 16,774$ 29,317$ 34,056$ 63,868
Net income per share:    
Basic (in dollars per share)$ 0.38$ 0.67$ 0.77$ 1.48
Diluted (in dollars per share)$ 0.37$ 0.61$ 0.73$ 1.35
Weighted-average shares outstanding:    
Basic (in shares)44,44143,64844,30443,293
Diluted (in shares)45,81948,34146,75947,195
Product revenues    
Revenues$ 246,565$ 213,970$ 706,246$ 589,006
Cost of revenues134,023110,743374,175303,597
Services and other revenues    
Revenues101,49482,432292,027231,978
Cost of revenues$ 54,941$ 38,880$ 156,864$ 112,027

OMCL Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 266,402$ 349,051
Accounts receivable and unbilled receivables, net of allowances of $5,012 and $5,272, respectively354,098240,894
Inventories147,096119,924
Prepaid expenses24,86222,499
Other current assets56,67448,334
Total current assets849,132780,702
Property and equipment, net88,35671,141
Long-term investment in sales-type leases, net33,80718,391
Operating lease right-of-use assets44,13348,549
Goodwill731,294738,900
Intangible assets, net251,004277,616
Long-term deferred tax assets16,61915,883
Prepaid commissions54,99463,795
Other long-term assets110,346127,519
Total assets2,179,6852,142,496
Current liabilities:  
Accounts payable73,51771,513
Accrued compensation42,79971,130
Accrued liabilities146,440133,167
Deferred revenues, net113,925112,196
Convertible senior notes, net0488,152
Total current liabilities376,681876,158
Long-term deferred revenues34,51920,194
Long-term deferred tax liabilities16,14051,705
Long-term operating lease liabilities41,86239,911
Other long-term liabilities9,2857,839
Convertible senior notes, net565,8030
Total liabilities1,044,290995,807
Commitments and contingencies (Note 13)
Stockholders’ equity:  
Preferred stock, $0.001 par value, 5,000 shares authorized; no shares issued00
Common stock, $0.001 par value, 100,000 shares authorized; 54,929 and 54,073 shares issued; 44,646 and 44,179 shares outstanding, respectively5554
Treasury stock at cost, 10,283 and 9,894 shares outstanding, respectively(290,319)(238,109)
Additional paid-in capital1,030,6651,024,580
Retained earnings419,136368,571
Accumulated other comprehensive loss(24,142)(8,407)
Total stockholders’ equity1,135,3951,146,689
Total liabilities and stockholders’ equity$ 2,179,685$ 2,142,496